Post My Press Release

Free Press Release Distribution

Author: chaitanyag (Page 1 of 33)

Positive Outlook for Bone Sonometer Market in 2019, But Will it Last?

Bone sonometer is also called as bone densitometry equipment in which sound waves on interaction with bone tissue gives information about elastic and structural properties of tissue. Bone faces slow degradation over period of time by microscopic fracture, fatigue damage, loss of bone mass with aging or nutritional deficiency at birth.  By assessing bone health, bone sonometer can predict the risk for osteoporosis and fracture due to this condition. Various peripheral skeletal sites that can be assessed with bone sonometer include calcaneus, phalanges of the hand, and tibia. In addition, it can also assess the structural and biomechanical properties of bones that contribute to bone strength.

Bone sonometer is comparatively safer technique against other densitometry equipment such as dual energy X-ray absorptiometry and peripheral quantitative computed tomography, which causes exposure to ionizing radiation. It is also simple to use and easy to move due to portability features. Moreover, bone sonometer measures bone in two dimensions, providing only an estimation of bone density. It is used to check mineral status in all age groups including children, adults, and geriatric population.

The global bone sonometer market size was valued at US$ 864.3 million in 2017, and is expected to witness a CAGR of 5.32% over the forecast period (2018 – 2026).

Request A Sample Copy Of This Report:

https://www.coherentmarketinsights.com/insight/request-sample/2269

Increasing incidence of fracture due to osteoporosis would be major reason for growth of the bone sonometer market. According to International Osteoporosis Foundation statistics in 2017, over 8.9 million fractures are caused due to osteoporosis, annually. Furthermore, according to same source, around 200 million postmenopausal women suffer from osteoporosis, globally. According to Centers for Disease Control and Prevention (CDC), in 2016, around 25% women aged 65 and above were suffering from osteoporosis of the femur neck or lumbar spine, and needed treatment. Such instances will in turn fuel growth of the bone sonometer market.

However, growth of bone sonometer market may be restrained majorly due to wider adoption of other scanning technique such as dual energy X-ray absorptiometry. These instruments are widely available and it takes short scanning time as against the quantitative ultrasound devices such as bone sonometer. Various new dual energy X-ray absorptiometry products are launched, which may hinder growth of the bone sonometer market. There is logical corollary between innovation in bone sonometer products and growth of the bone sonometer market, especially in developed regions such as North America and Europe that already has one of the highest per capita expenditure and strong healthcare infrastructure.

Most of the key manufacturers of bone sonometer are focusing on providing portable models, which can be easily connected with computers and digital platforms, take less amount of examination time, and easy to carry anywhere. Pegasus Smart is one such bone sonometer by DMS imaging, which takes only about one second to examine bone density at peripheral bones. It can store up to 300 examination images and these images can be transferred to laptop or computer on permanent workstation such as electronic health record or population health management, for easy access. Some devices offer age group specific configuration (neonatal, pediatric, and adults) and multisite density scanning as against traditional bone sonometer that is mostly used at calcaneus and phalanges.

Moreover, according to the analysis by Coherent Market Insights, increasing number of geriatric population worldwide, is expected to propel growth of the bone sonometer market. Geriatric populations are the most affected age group from bone fracture due to lowered bone density level. Early estimation of bone health could significantly save incidence of fractures. According to the World Population Prospects Report, published in 2017, the worldwide population is advancing toward higher age group. In 2017, an estimated 962 million people were aged 60 years or over, which comprised 13% of the population, worldwide. Moreover, the number is expected to reach 1.3 billion by 2025, registering a growth of around three percent, annually.

Key players operating in the global bone sonometer market include Hologic, Inc., GE Healthcare, Echolight, DMS Imaging, Osteocys Co. Ltd., BeamMed Ltd., Medilink, and Furuno Electric Co., Ltd.

Click To Reading More On Bone Sonometer market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Oncology Drugs Market Product Opportunity, Industry Summary, Constraints

The global Oncology Drugs Market size is estimated to be valued at US$ 77.3 billion in 2018 and is expected to witness a CAGR of 12.3% over the forecast period (2018 – 2026).

Cancer is a class of chronic disease that is characterized by uncontrolled growth of cells. The most common cancer types are breast cancer, lung cancer, colorectal cancer, uterine cancer, and thyroid cancer. The three main types of drugs used for cancer, based on their mechanism of action, are cytotoxic drugs, targeted drugs, and hormonal drugs. Oncology drugs market has witnessed tremendous growth in the recent past, owing to increasing drug approvals and emergence of biosimilar products for cancer treatment. Furthermore, increasing healthcare expenditure for cancer has led to growing research and development activities for developing new cancer drugs that are highly effective and with least side-effects.

Key companies in the oncology drugs market are focused on targeting cancer treatment based on personalized medicines. According to Tufts Center for the Study of Drug Development (CSDD), 2015 report, 73% of the cancer medicines in the development have potential to be personalized medicine. Several researches are focused on targeting cancer at molecular level to offer new cancer treatments. According to an article published in The Biopharmaceutical Pipeline, 2013, new molecular entity for cancer treatment holds 80% share in the total pipeline products for cancer treatment. According to same source, the total number of potential first-in-class projects for cancer are 4,358 out of total 5,473 cancer projects.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/2332

However, several blockbuster oncology drugs are expected to lose their patent during 2018-2020, which in turn is expected to hamper the market growth during the forecast period. For instance, Roche’s Avastin, which is a humanized monoclonal antibody for the indication of colorectal, lung, breast, glioblastoma, kidney, and ovarian cancer is expected to lose its patent in July 2019 in the U.S. and in January 2022 in Europe. Some of the other drugs that are under patent expiration include, Bristol-Myers Squibb and Eli Lilly and Company’s Erbitux (cetuximab) by 2018; Roche’s Herceptin (trastuzumab) by 2019 and MabThera (Rituximab) by 2018; and Sanofi’s Zaltrap by 2020.

Presence of key market players and increasing drug approvals are attributing to the highest share of North America market in the global oncology drugs market

Regional oncology drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America oncology drugs market holds dominant position in the global oncology drugs market. Advanced medical treatment options available for cancer in economies such as the U.S. and increasing survival rate are key factors driving the market growth. For instance, according to the American Association for Cancer Research’s 2015 report, the number of survivors suffering from cancer increased from 9.8 million in 2001 to 14.5 million in 2014, owing to increasing adoption of better medical facilities. Moreover, increasing R&D activities by local players such as Spark Therapeutics, Inc. and Kite Pharmaceuticals and increasing product approvals by the U.S. FDA are boosting the market growth in North America.

Furthermore, Asia Pacific is expected to witness significant growth in the market, owing to increasing focus of international player on strategies such as mergers and acquisitions. For instance, in February 2018, Merck acquired Viralytics Limited, a Sydney-based immune-oncology drug developer, to strengthen its immune-oncology drug pipeline. Moreover, increasing prevalence of various types of cancer in economies such as India and China is also expected to propel growth of the market. For instance, according to the American Cancer Society, 2015, around 4.3 million new cancer cases and over 2.8 million cancer deaths were recorded in China, with lung cancer being the most common and the leading cause of cancer deaths.

Click To Reading More On Oncology Drugs Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Intraoperative Monitoring Electrodes Market Insights,Status, Government Policies and Outlook

Intraoperative monitoring electrodes offers useful, real-time ECG data during various mapping or monitoring procedures and are used to transfer energy of ionic currents into electrical current in the body. The currents passed into the body are amplified and used for diagnosis of various diseases. Intraoperative monitoring electrodes offers useful, real-time ECG data during various mapping or monitoring procedures. These electrodes are specifically used in neurological surgery to assess function of the somatosensory pathways during surgical procedures in which the spinal cord, brainstem or cerebrum is at risk to get injured and to localize the sensorimotor cortex.

Intraoperative Monitoring Electrodes Market Drivers

Increasing number of cardiology and neurological diseases worldwide is expected to drive growth of the intraoperative monitoring electrodes market. For instance, according to the World Health Organization (WHO) estimates, in 2012, the global geriatric population was pegged at 901 million in 2015, which is expected to increase over 2 billion by 2050. Geriatric population is highly susceptible to various cardiac and neurological diseases, in turn propelling demand for early disease diagnosis, which can be achieved using monitoring electrodes.

Furthermore, increasing preference for minimally invasive treatment procedures, use of nanotechnology for developing miniaturized electrodes, growing investments on research and development, and focus on early diagnosis of diseases are further expected to boost the global intraoperative monitoring electrodes market growth.

Technological advancement in the field of monitoring electrodes have resulted in high demand for intraoperative monitoring electrodes. For instance, in January 2015, researchers at North Carolina State University introduced a new dry sensor to monitor Electrocardiography (ECG) and Electromyography (EMG) all day long with excellent accuracy, even in situations when wet sensors are ineffective.

Request A Sample Copy Of This Report:

https://www.coherentmarketinsights.com/insight/request-sample/2362

Intraoperative Monitoring Electrodes Market Regional Analysis

North America is expected to hold a dominant position in the global intraoperative monitoring electrodes market over the forecast period, owing to the high incidence of neurological and cardiovascular disorders, increasing demand for technologically advanced electrodes, and growing adoption of non-invasive diagnostic electrodes in these region.

According to the Alzheimer’s Association estimates in 2017, around 5 million Americans were diagnosed with Alzheimer’s disease and the number is expected to increase over 16 million by 2050. This creates a highly conducive environment for growth of the intraoperative monitoring electrodes market in North America, especially for neurological applications. Furthermore, installation of technologically advanced electrocardiogram (ECG) and electromyogram (EMG) electrode system by end users have contributed towards the deployment and higher sales of the intraoperative electrode devices in North America.

Intraoperative Monitoring Electrodes Market Restraint

Risk of needle-stick injuries associated with use of subdermal needle electrodes during intraoperative monitoring is expected to limit adoption of intraoperative monitoring electrodes over the forecast period. For instance, according to the data published in Journal of Neurosurgical Anesthesiology in January 2014; there is need to employ steps to minimize the needle sticks, which are used during intraoperative neurophysiologic monitoring (IONM).     

Intraoperative Monitoring Electrodes Market Key Players

Key players operating in global intraoperative monitoring electrodes market include DIXI Medical, Ambu A/S, Blackrock Microsystems LLC, Digitimer Ltd., Cognionics, Inc., Rhythmlink International, LLC, Unimed Electrode Supplies, 3M Company, NuVasive, Inc., Computational Diagnostics, Inc., and Natus Medical Incorporated.

Click To Reading More On Intraoperative Monitoring Electrodes Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

CpG Oligodeoxynucleotide Market Competitive Landscaping and Recent Developments

CpG oligodeoxynucleotide (CpG ODN) is a synthetic oligodeoxynucleotide, which contains unmethylated CpG motifs derived from bacterial DNA with immunostimulatory activities. CpG ODN is a short single-stranded synthetic DNA molecule, which contains one of each of cytosine triphosphate deoxynucleotide and guanine triphosphate deoxynucleotide that makes up the C component in the molecule.

The CpG motifs are considered pathogen-associated molecular patterns (PAMPs), as they are present in microbial genomes in abundance, but are rarely present in vertebrate genomes. These CpG PAMPs are recognized by the pattern recognition receptor (PRR) toll-like receptor 9 (TLR9), which is constitutively expressed only in B cells and plasmacytoid dendritic cells (pDCs) in humans and other higher primates. CpG ODNs show great potential for attachment in prophylactic vaccines designed to prevent infection. Various research companies are targeting synthetic CpG ODN due to the type I pro-inflammatory response it produces and its successful use as vaccine adjuvants.

CpG Oligodeoxynucleotide Market – Dynamics

Increasing demand for vaccination across the globe is expected to contribute to significant growth of the CpG oligodeoxynucleotide market over the forecast period. For instance, according to the UNICEF-Vaccination & Immunization Statistics, in 2017, around 123 million children got immunized with lifesaving vaccines across the world. Moreover, according to the Centers for Disease Control and Prevention (CDC), at least 3,153,876,236 doses of vaccines were distributed in the U.S. from 2006 to 2016.

Rising prevalence of new chronic diseases and the demand for reducing the occurrence of childhood diseases such as polio and others are expected to propel growth of the CpG oligodeoxynucleotide market. According to the Centers for Disease Control and Prevention (CDC), around 25.3 per 100,000 children die at the age of 1-4 years due to congenital malformations, deformations, and chromosomal abnormalities, and others.

Request A Sample Copy Of This Report:

https://www.coherentmarketinsights.com/insight/request-sample/2367

CpG Oligodeoxynucleotide Market – Regional Insights

On the basis of geography, the global CpG oligodeoxynucleotide market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America held dominant position in the global CpG oligodeoxynucleotide market in 2017. This is owing to high mortality due to various diseases such as pneumonia, diphtheria, pertussis, and others is expected to propel growth of the market in this region. For instance, according to the Centers for Disease Control & Prevention (CDC), in 2016, around 48,632 children died from pneumonia, which was around 15.1 per 100,000 population in the U.S.  

Moreover, Asia pacific is expected to witness significant growth in the CpG oligodeoxynucleotide market, owing to rising focus on R&D along with mass manufacturing of cheap and affordable vaccines in the region. For instance, according to the International Vaccine Institute (IVI), India became the new hub for vaccine research with over 60% of the world’s vaccines manufactured in India in 2016.

CpG Oligodeoxynucleotide Market – Competitive Landscape

Major players operating in the global CpG oligodeoxynucleotide market include Novus Biologicals, InvivoGen, Merck KGaA, Hycult Biotech, Miltenyi Biotec, Sapphire Bioscience, Biomol GmbH, and Cosmobio. Key players are focused on adopting market strategies such as mergers and acquisitions, and new product development, in order to retain dominant position in the market. For instance, in July 2014, Techne Corporation acquired Novus Biologicals, a Colorado-based supplier of outsourced and in-house developed antibodies for life science research, for around US$ 60 million in cash.

Click To Reading More On CpG Oligodeoxynucleotide Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Optogenetics Actuators & Sensors Market Competitive Landscape ,Trends and Growth

Optogenetics Actuators & Sensors Market – Market Dynamics

Factors responsible for growth of the optogenetics actuators & sensors market are rise in burden of retinal disease and neurological disorders, rapid development and research in the field of optogenetics, and government initiatives such as funding support for development of this field. Optogenetics allow to understand which biochemical and physiological pathway is working for cause of particular disease, which may help to find treatment for particular disease by flashing blue light on specific neural cells. According to World Health Organization’s factsheet in 2016, age-related macular degeneration (AMD) ranked third among the global causes of visual impairment with a blindness prevalence of 8.7 %. Age-related macular degeneration is the primary cause of visual deficiency in industrialized countries. Alzheimer’s disease is another potential area in which optogenetics could give sustainable treatment solution. According to World Alzheimer Report in 2016, there were an estimated 46.5 million Alzheimer’s disease patients across the world. Moreover, every three second, one new case of Alzheimer’s disease is registered, worldwide.

Optogenetics Actuators & Sensors Market – Regional Insights

On the basis of geography, optogenetics actuators & sensors market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the dominant region in the optogenetics actuators & sensors market. Most of the optogenetics related research is ongoing in the U.S., which is why it serves as a conducive environment for growth of the market. There is strong government funding to carry research and development in this field as optogenetics has potential to better understand pathophysiology in chronic neural disease such as Alzheimer’s disease and Parkinson’s disease, which has high prevalence rate in the U.S. National Institute of Mental Health of the National Institutes of Health (NIH) in 2016, awarded grant of US$ 1.4 million to Max Planck Florida Institute for Neuroscience and NYU Langone Medical Center for research in optogenetics. Companies such as GenSight Biologics have its optogenetics research platform GS030 in preclinical stage. 

Optogenetics Actuators & Sensors Market – Competitive Landscape

Key players present in the optogenetics actuators & sensors market are Bruker, Circuit Therapeutics, Inc., Gensight Biologics, AGTC, Prizmatix, Merck KGaA, Elliot Scientific Ltd., Coherent, Inc., The Jackson Laboratory, Scientifica (Judges Scientific Plc Company), Addgene, Shanghai Laser & Optics Century Co., Ltd. (SLOC), Noldus Information Technology, Thorlabs, Inc., and Danaher.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/2378

Optogenetics Actuators & Sensors Market – Market Taxonomy

On the basis of actuators, the global optogenetics actuators & sensors market is segmented into

Channelrhodopsin,Halorhodopsin,Archaerhodopsin

On the basis of sensors, the global optogenetics actuators & sensors market is segmented into

Genetically Encoded Calcium Indicators,Voltage-Sensitive Fluorescent Proteins,pH Sensors

Optogenetics is the technique in which optically-activated proteins are used to control neuronal function. It is one of the recent development in neuroscience, which provides treatment options to incurable disease such as retinal diseases, Parkinson’s, and Alzheimer’s disease. Optogenetic techniques allow activation or inhibition of the specific neurons with a high degree of spatial, temporal, and neurochemical precision. In this technique, gene which code for light sensitive protein is taken out of algae species. This protein is actually act as ion channel that opens or close in response to specific wavelength of light. The gene which code for this protein is inserted into specific neuron in the brain and it express to produce this light sensitive protein. On flashing light on specific neural cell, there is conduction of the neural signal. This technique can be utilized to control movement of neuron and to understand functioning of brain cells at cellular level.

Click To Reading More On Optogenetics Actuators & Sensors Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Enteral Syringe Market Breaking down into Type, Application and Regions

Enteral syringes are majorly used for administering drugs and nutritional therapy through oral, rectal or sublingual route of administration. They are commonly used in hospitals, clinics, and homes and are available in range of 1ml to 60 ml. Newly launched enteral syringes are designed and manufactured to meet latest international standard ISO-80369-3. Drugs can be directly placed into the gastro-intestinal tract through enteral route. Enteral syringes are most widely used for delivering oral liquid medication and nutrition. These syringes works like enteral feedings in its function and end use. Enteral syringes come with purple plunger, which indicates that that the medication in the syringe must be administered via enteral route. Purple color is used in order to separate these syringes from IV syringes. These syringes are utilized for various purpose such as correct measurement of liquid medicine to be administered to patient in situation where dose cannot be accurately measured using a medicine cup or spoon, for administering medicine to infants and young children, and administering controlled drug liquid medicines. These syringes are available in different types such as single use syringes and home use syringes.    

The global enteral syringe market size was valued at US$ 575.6 million in 2017 and is expected to witness a CAGR of 4.9% over the forecast period (2018 – 2026).

Increasing number of critical care and neonatal intensive care unit admissions is expected to drive growth of the global enteral syringes market. This is owing to inability of patients admitted to critical care and newborns admitted to neonatal intensive care (due to premature birth or other complications) to swallow medicine or take nutrition. According to statistics given by Bliss Organization, over 95,000 newborns are admitted to neonatal units in the U.K, annually due to premature birth (before 37 weeks of pregnancy) or due to full term (after 37 weeks) yet sick birth. Moreover, according to same source around 1 in every 8 newborns in the U.K are admitted to neonatal units, annually.

Request A Sample Copy Of This Report:

https://www.coherentmarketinsights.com/insight/request-sample/2398

Furthermore, increasing geriatric population is expected to boost the market growth over the forecast period. People above 60 years of age are more prone to illness or injuries that often require hospital admissions and nutritional therapy and medication administration via enteral syringe. According to United Nations report: World Population Prospect-The 2017 Revision, worldwide geriatric population is expected to increase from 962 million in 2017 (13% of worldwide population) to 1.3 billion by 2030 and will reach to 2.1 billion by 2050. According to same source, worldwide geriatric population is increasing at a rate of 3%, annually and around all regions, except Africa, are expected to register geriatric population of over 25% by 2050.  

Regulatory guidelines for design and manufacturing of enteral devices including enteral syringe were recently updated by various regulatory bodies. In 2015, new design standards were introduced in enteral feeding sets, enteral syringes, and enteral feeding tubes referred as ENFit. ENFit is a new connection standard that is developed by an international group of clinicians, manufacturers body Global Enteral Device Supplier Association (GEDSA), and regulators under aegis of Stay Connected initiative to prevent tubing misconnections and patient injury. Tubing misconnection occurs when enteral devices are connected to non-enteral devices such as IV lines, urinary catheters, and ventilator tubing. Global Enteral Device Supplier Association (GEDSA) promotes safe use of enteral devices including syringes. Market players that comply with ENFit standard design are receiving 510(k) clearance from the U.S Food and Drug Administration (U.S. FDA). For instance, in 2016, NeoMed and Medtronic received the U.S FDA 510(k) clearance for low dose tip ENFit syringes. NeoMed has offered royalty-free access of its design to all syringe manufacturers. Therefore, several manufacturers can implement this design standard to promote safe use of these devices, which in turn is expected to increase adoption of enteral syringes.

Key players operating in the global enteral syringe market include, B. Braun Melsungen AG, GBUK Enteral Ltd., Thermo Fischer, Inc., Koninklijke Philips N.V., Miktell Ltd., Baxter International, Inc., Cardinal Health, Inc., Terumo Corporation, Kentec Medical, Inc., Vygon S.A., and others.

Click To Reading More On Enteral Syringe Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Cranial Stabilization Devices Market Product Opportunity, Industry Summary, Constraints, Threat

Cranial stabilization is a process of making the cranial nerves stable for brain surgery. Brain surgery is also known as craniotomy. A craniotomy is dependent on the nature of brain problem. It is majorly performed to aid in treatment of brain tumors, hematomas (blood clots), aneurysms or arteriovenous malformation (AVM), traumatic head injury, foreign objects (bullets), swelling of the brain, or infection.

Cranial Stabilization Devices Market – Drivers

Increasing prevalence of neurological disorders is expected to boost the cranial stabilization devices market growth during the forecast period. For instance, in 2015, Global Burden of Disease Study surveyed that neurological disorders are the major cause of disability and death worldwide. The burden of neurological disorders has increased by 36·7% over the past 25 years from 1990 to 2015.

Cranial Stabilization Devices Market – Restraints

Several medical device reimbursement challenges is expected to hamper the cranial stabilization devices market growth.  In many countries, the medical device reimbursement rates are based on standing formulas applied to the procedure or types of device and not on the technology or features of the individual manufacturer. This prevents medical device manufacturing companies to invest in the development of medical devices with advanced technologies.

Request A Sample Copy Of This Report:

https://www.coherentmarketinsights.com/insight/request-sample/2410

Cranial Stabilization Devices Market – Regional Analysis

On the basis of region, the global cranial stabilization devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing merger and acquisition activities in North America are expected to drive the cranial stabilization devices market size in the region. For instance, in October 2017, Integra LifeSciences Holdings Corporation acquired the Johnson & Johnson’s Codman Neurosurgery business. The Codman Neurosurgery business offers a portfolio of devices focused on hydrocephalus management, neuro intensive care, and cranial surgery. The deal was closed for US$ 1.045 billion.

Furthermore, Asia Pacific is expected to witness significant cranial stabilization devices market growth, owing to increasing initiatives by various organizations to promote the development of clinical neurology and neurological science in Asia Pacific. For Instance, in November 2018, the Asian and Oceanian Association of Neurology (AOAN) hosted the conference: The Asian Oceanian Congress of Neurology 2018 (AOCN 2018), to provide participants (neurologists) an unparalleled insights into the latest research, developments, and treatments in the field of neurosciences through its comprehensive scientific program led by regional neurology experts.

Key Players in the Cranial Stabilization Devices Market:

Key players operating in the cranial stabilization devices market include, Integra Lifesciences Holdings Corporation, Jintan Huida Medical Instrument Co. Ltd., B. Braun Melsungen AG, DePuy Synthes, evonos GmbH & Co. KG, Jeil Medical Corporation, Medtronic, Micromar, NEOS Surgery, OsteoMed, Pro Med Instruments, Stryker, and Zimmer Biomet.

Click To Reading More On Cranial Stabilization Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Nucleic Acid Isolation and Purification Market Global Opportunities, Share, Key Players

High quality DNA and RNA are important for a wide variety of research and clinical applications. Purification or isolation of nucleic acids is the first step in most molecular biological studies and in all recombinant DNA techniques. The extraction of nucleic acids from biological material requires cell lysis, inactivation of cellular nucleases, and separation of the desired nucleic acid from cellular debris. Methods for purifying nucleic acids from cell extracts are often combinations of extraction/precipitation, chromatography, centrifugation, electrophoresis, and affinity separation. Pure nucleic acid has applications in emerging fields such as genetic engineering, molecular diagnosis, forensics, and research related to life sciences.

Nucleic Acid Isolation and Purification Market Drivers

Increasing demand for nucleic acid test that is required for pipeline studies of genetic engineering and molecular diagnostics is the key driver for nucleic acid isolation and purification market growth. For Instance, in September 2012, GlaxoSmithKline initiated Phase 1 clinical study to evaluate the effects of chemotherapy and adoptive immunotherapy with T cells engineered to recognize NY-ESO-1 peptide in patients with unresectable, metastatic or recurrent synovial sarcoma. T immune cells are genetically engineered to express tumor-specific T cell receptor (TCR) genes and thereby kill cancer cells. The study is expected to complete by May 2020.

However, low adoption of automated nucleic acid isolation and purification procedures in emerging economies is a key factor restraining the global nucleic acid isolation and purification market growth.

Request A Sample Copy Of This Report:

https://www.coherentmarketinsights.com/insight/request-sample/2420

Nucleic Acid Isolation and Purification Market- Regional Analysis

On the basis of region, the global nucleic acid isolation and purification market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing merger and acquisition activities in North America are expected to drive the nucleic acid isolation and purification market size. For Instance, in May 2018, Agilent Technologies Inc. acquired Lasergen, Inc. in a US$ 105 million deal. The collaboration has been done to develop next-generation sequencing workflow solutions for clinical applications.

Furthermore, key players in Europe are focused on adopting acquisition strategies in order to enhance their market share. This in turn is expected to boost growth of the nucleic acid isolation and purification market in the region. For Instance, in February 2017, Qiagen Inc. acquired OmicSoft Corp. OmicSoft is recognized for its suite of software solutions that enable researchers to analyze and visualize their own datasets and compare them to massive volumes of publicly available ‘omics’ datasets. This acquisition aims at adding feature to the management, analysis, and sharing of both primary data and analyzed results, while also expanding the range of Qiagen’s translational and clinical applications.

Key players operating in the nucleic acid isolation and purification market include QIAGEN Inc., Thermo Fisher Scientific., F. Hoffmann-La Roche Ltd, Merck KGaA,, Agilent Technologies Inc., Illumina, Inc., Takara Bio Inc., Promega Corporation, General Electric Company, Danaher Corporation, New England Biolabs, and Bio-Rad Laboratories.

Click To Reading More On Nucleic Acid Isolation and Purification Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Page 1 of 33

Powered by WordPress & Theme by Anders Norén